Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elicitation of the Phoenix Sign With Non-guided Subcutaneous D5W Infiltration
NCT07568470Enrolling by invitation
- Sponsor
- US Neuropathy Centers
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Dextrose in water in foot drop, sponsored by US Neuropathy Centers. Primary endpoints: Changes in motor strength of dorsiflexion of the anterior and lateral compartments of the lower extremity at 1 day, Presence of absence of increase in motor strength of the lower extremity in dorsiflexion at 1 day and 1 more. Started Apr 2026; status: enrolling by invitation.
02
Drugs
Dextrose in water
03
Conditions
foot drop
Beyond the preview
Go deeper on NCT07568470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568470.